Checking kidney side effects from immune cancer medicines
Part of Cancer clinical trials.
This study looks at how immune checkpoint medicines (sometimes combined with other treatments like chemotherapy) may affect the kidneys. It may help doctors better prevent or manage kidney side effects in people starting these therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to start immune cancer treatment (or immune combination treatment, sometimes with platinum chemotherapy).
- You are not in end-stage/terminal illness with no expected meaningful recovery.
- You are willing to sign an informed consent form after discussing study details.
- You can follow the study’s basic screening and safety checks before starting treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological signals (biomarkers) that might predict who will experience side effects from immune checkpoint inhibitor cancer treatments. By understanding these signals early, doctors may be able to better manage or prevent serious immune-related complications.
This study is for people with cancer who are already receiving immunotherapy (checkpoint inhibitors). It aims to build an early warning system to help detect and manage possible organ damage or other side effects from the treatment, using advanced testing to keep you safer.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This trial tests whether the drug infliximab can help treat kidney damage caused by immunotherapy (checkpoint inhibitors). It is for people whose kidneys suddenly fail due to inflammation, and who haven't already had strong immune-suppressing treatment for this problem.
This study looks at how certain cancer drugs (called immune checkpoint inhibitors) interact with other medicines in the body. It aims to help doctors understand how to safely combine these treatments.
This study tries to predict who is more likely to get serious side effects from immune checkpoint medicines used for solid tumors. You may help researchers by answering questionnaires before treatment and during follow-up, and by possibly storing sample specimens.
Hear when a new Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.